38 Results for "

anticoagulant effects

" in MedChemExpress (MCE) Product Catalog:
Products (38)

38 Results for "anticoagulant effects" in MCE Product Catalog:

33
33 Publications Verification
Cat. No.: HY-D0836
CAS No.: 25102-12-9
Synonyms: Ethylenediaminetetraacetic acid dipotassium dihydrate
EDTA dipotassium dihydrate is a metal ion chelator that forms stable and water-soluble chelates with a variety of metal ions. EDTA dipotassium is commonly used as a blood anticoagulant, which can effectively prevent blood coagulation and maintain the morphology and function of cells in blood samples. In the industrial field, EDTA dipotassium can be used to remove the adverse effects of metal ions and prevent oxidation and deterioration caused by metal ions .
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-P1929
CAS No.: 128270-60-0
Bivalirudin, a hirudin analog and anticoagulant, is a direct thrombin inhibitor. Bivalirudin inhibits thrombin-mediated fibrinogen cleavage, coagulation factor activation, and platelet activation by reversibly binding to thrombin. In addition, Bivalirudin also has certain effects of anti-virus, anti-inflammation, and vascular endothelial barrier function protection. Bivalirudin can be used for the research of thrombotic diseases and others .
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-15664
CAS No.: 1191386-55-6
Purity:  99.89%
Bivalirudin TFA, a hirudin analog and anticoagulant, is a direct thrombin inhibitor. Bivalirudin TFA inhibits thrombin-mediated fibrinogen cleavage, coagulation factor activation, and platelet activation by reversibly binding to thrombin. In addition, Bivalirudin TFA also has certain effects of anti-virus, anti-inflammation, and vascular endothelial barrier function protection. Bivalirudin TFA can be used for the research of thrombotic diseases and others .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-114164H
CAS No.: 9002-04-4
Synonyms: EC 3.4.21.5 (Lyophilized); Human Alpha Thrombin (Lyophilized)
Human α-Thrombin (EC 3.4.21.5; Human Alpha Thrombin) (Lyophilized) is a terminal serine protease in the coagulation cascade, as well as a potent physiological platelet agonist and fibrin-generating enzyme in vivo. Human α-Thrombin catalyzes the conversion of fibrinogen to fibrin for blood clot formation, and activates platelet aggregation by cleaving the protease-activated receptors PAR1 (major) (Kd = 1 nM) and PAR4 (minor) on the platelet surface to expose tethered ligands. Human α-Thrombin also amplifies coagulation via positive feedback by activating coagulation factors V, VIII, XI (FV/FVIII/FXI), and switches to activate protein C to exert anticoagulant effects after binding to thrombomodulin .
This product is in a freeze-dried form.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-10274
CAS No.: 211915-06-9
Purity:  99.84%
Synonyms: BIBR 1048
Target:  

Thrombin

Research Areas:  

Cardiovascular Disease

Dabigatran etexilate (BIBR 1048) is an orally active proagent of Dabigatran (a direct inhibitor of thrombin). Dabigatran etexilate has anticoagulant effects and is used for the prophylaxis of venousthromboembolism and stroke due to atrial fibrillation .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-P2813
CAS No.: 8001-27-2
Hirudin is a thrombin inhibitor with blood anticoagulant property. Hirudin has potent anti-thrombotic, wound repair, anti-fibrosis, anti-tumor and anti-hyperuricemia effects. Hirudin also affects diabetic complications, cerebral hemorrhage, and others .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-10274A
CAS No.: 872728-81-9
Purity:  99.77%
Synonyms: BIBR 1048MS; Dabigatran etexilate methanesulfonate
Target:  

Thrombin

Research Areas:  

Cardiovascular Disease

Dabigatran etexilate mesylate (BIBR 1048MS) is an orally active proagent of Dabigatran (a direct inhibitor of thrombin). Dabigatran etexilate mesylate has anticoagulant effects and is used for the prophylaxis of venousthromboembolism and stroke due to atrial fibrillation .
loading...
    loading...
Cat. No.: HY-111186
CAS No.: 90035-08-8
Purity:  99.17%
Synonyms: WL 108366
Research Areas:  

Others

Flocoumafen (WL 108366) is an orally active vitamin K epoxide reductase inhibitor and a multi-target ligand, which includes prostaglandin F synthase, serum albumin, glucocorticoid receptor 2, and MMP-9. Flocoumafen is a second-generation anticoagulant rodenticide (ARs) with a half-life of 177.4 hours and has deadly anticoagulant effects .
loading...
    loading...
Cat. No.: HY-P99794
CAS No.: 2056878-75-0
Synonyms: BAY 1213790

Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

Osocimab (BAY 1213790), an anti-FXIa antibody (Ki=2.4 nM; EC50=0.2 nM). FXI inhibition may reduce the risk of thrombosis. Osocimab inhibits thrombin generation, and prolongs activated partial thromboplastin time. Osocimab exhibits anticoagulant effects .
loading...
    loading...
Cat. No.: HY-N1400
CAS No.: 80952-71-2
(20R)-Ginsenoside Rh1 is the R-isomer of Ginsenoside Rh1 (HY-N0604), and it is found in red ginseng, ginseng, and other sources. (20R)-Ginsenoside Rh1 inhibits thrombin-induced conversion of fibrinogen to fibrin, exerting anticoagulant and antithrombotic effects .
loading...
    loading...
Cat. No.: HY-18660
CAS No.: 1438492-26-2
Synonyms: PER977
Target:  

Factor Xa Thrombin

Research Areas:  

Cardiovascular Disease

Ciraparantag (PER977) is a thrombin and factor Xa inhibitor. Ciraparantag is a broad-spectrum reversal agent for anticoagulants, including low-molecular-weight heparin, unfractionated heparin, and certain direct oral anticoagulants. It is reported to antagonize the effects of all coagulants except VKAs and agratroban .
loading...
    loading...
Cat. No.: HY-P2933
CAS No.: 42617-41-4
Activated protein C is an anticoagulant targeting coagulation factors Va and VIIIa. Activated protein C demonstrates cytoprotective effects through binding to endothelial cell protein C receptor (EPCR) and protease-activated receptor-1 (PAR-1), regulating gene expression, anti-inflammation, anti-apoptosis, and stabilizing endothelial barriers. Activated protein C is promising for research of diseases such as severe sepsis and ischemic stroke .
loading...
    loading...
Cat. No.: HY-P4325
CAS No.: 109528-50-9
Target:  

Thrombin

Research Areas:  

Others

Hirudin (55-65) (sulfated) is a fragment of Hirudin with anticoagulant effects. Hirudin is a thrombin inhibitor with blood anticoagulant property.
loading...
    loading...
Cat. No.: HY-108739
CAS No.: 1362509-93-0
Synonyms: BI 655075

Target:  

Thrombin

Research Areas:  

Cardiovascular Disease

Idarucizumab is a humanized monoclonal antibody fragment. Idarucizumab is first reversal agent for a direct oral anticoagulant (DOAC). Idarucizumab can specifically neutralize the effects of the oral direct thrombin inhibitor in order to restore hemostasis .
loading...
    loading...
Cat. No.: HY-10274R
CAS No.: 211915-06-9
Synonyms: BIBR 1048 (Standard)
Research Areas:  

Cardiovascular Disease

Dabigatran etexilate (Standard) is the analytical standard of Dabigatran etexilate. This product is intended for research and analytical applications. Dabigatran etexilate (BIBR 1048) is an orally active proagent of Dabigatran (a direct inhibitor of thrombin). Dabigatran etexilate has anticoagulant effects and is used for the prophylaxis of venousthromboembolism and stroke due to atrial fibrillation .
loading...
    loading...
Cat. No.: HY-10274S
CAS No.: 2749293-92-1
Purity:  99.28%
Dabigatran etexilate-d13 is the deuterium labeled Dabigatran etexilate. Dabigatran etexilate (BIBR 1048) is an orally active proagent of Dabigatran. Dabigatran etexilate has anticoagulant effects and is used for the prophylaxis of venousthromboembolism and stroke due to atrial fibrillation .
loading...
    loading...
Cat. No.: HY-14853
CAS No.: 365462-23-3
Purity:  98.05%
Synonyms: YM150
Research Areas:  

Cardiovascular Disease

Darexaban (YM150) is a potent, selective and orally active factor Xa (FXa) inhibitor with an IC50 of 54.6 nM. Darexaban shows high selectivity against other related serine proteases, such as trypsin, thrombin, and kallikrein. Darexaban has anticoagulant and antithrombotic effects .
loading...
    loading...
Cat. No.: HY-15759A
CAS No.: 159668-20-9
Synonyms: Ro 46-6240 hydrate; Ro 46-6240/010 hydrate
Target:  

Thrombin

Research Areas:  

Cardiovascular Disease

Napsagatran (Ro 46-6240) hydrate is a potent thrombin inhibitor. Napsagatran hydrate exhibits anticoagulant effects in vitro and in vivo. Napsagatran hydrate can be used in antithrombotic research [1][2].
loading...
    loading...
Cat. No.: HY-172316
CAS No.: 2915316-40-2
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

BAY 3389934 is a selective dual inhibitor of factor IIa and factor Xa, with an IC50 of 4.9 nM for factor IIa and an IC50 of 0.66 nM for factor Xa. BAY 3389934 directly inhibits the activities of factor IIa and factor Xa and regulates the common coagulation pathway. BAY 3389934 exhibits anticoagulant and organ-protective effects. BAY 3389934 can be used in the research of sepsis and coagulopathy .
loading...
    loading...
Cat. No.: HY-172231
CAS No.: 110346-23-1
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cardiovascular Disease Cancer

Hexolame is an estrogen receptors agonist with dual anticoagulant and estrogenic properties. Hexolame binds to estrogen receptors to induce anticoagulant effects by modulating clotting factors or platelet activity. Hexolame is promising for research of prostatic cancer and prevention of thrombosis .
loading...
    loading...